BioCentury | Jan 26, 2021
Product Development

Moderna’s two-pronged approach to combating emerging SARS-CoV-2 variants

...SARS-CoV-2 variants by evaluating an additional booster shot...
...announced plans to test a second booster shot...
BioCentury | Jan 15, 2021
Product Development

Phase I/II antibody levels support single shot for J&J COVID-19 vaccine: Data Byte

...imminent Phase III readout for a single shot...
...trial, 18-55 year-old volunteers given a single shot...
...did not prevent response to a booster shot...
BioCentury | Jan 9, 2021
Product Development

The unfolding dosing controversy for COVID vaccines

...favor of giving more people their first shot...
...manufacture sufficient doses to provide a second shot...
BioCentury | Jan 8, 2021
Product Development

Caplan sees a host of bioethical turning points coming out of the pandemic

The reckoning that will come after the pandemic will see broad if not tectonic shifts in drug development, from clinical trial conduct to scientific publishing, according to bioethicist Arthur Caplan....
BioCentury | Jan 6, 2021
Product Development

Two half or full shots of Moderna COVID vaccine yield similar antibody levels: Data Byte

...responses in the company’s Phase I trial. Both studies found that prior to the booster shot...
BioCentury | Jan 5, 2021
Regulation

FDA says don’t mess with dosing schedules for COVID vaccines

...Inc. (NYSE:PFE) will be able to manufacture sufficient doses of Comirnaty (BNT162b2) to provide a second shot...
BioCentury | Dec 31, 2020
Politics, Policy & Law

Innovations forged in the COVID crucible will reshape medicine

...development of mRNA vaccines is also a shot...
BioCentury | Dec 31, 2020
Product Development

Stoffels on how J&J designed its COVID-19 vaccine for maximum impact: a BioCentury audio interview

...the need for creating and maintaining systems to remind people to return for a second shot...
BioCentury | Dec 30, 2020
Product Development

2020’s silver linings, New Year’s hopes: a BioCentury podcast

...biopharma companies. The editors also take a shot...
BioCentury | Dec 29, 2020
Product Development

Arcturus undeterred by low neutralizing titers from COVID vaccine in Phase I; shares slide

...and three, respectively. Mean titers in both trials’ subjects rose over 10-fold after a second shot. Sandi...
Items per page:
1 - 10 of 627